Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease

Y Nagai1, S Ueno, Y Saeki

  • 1Department of Neurology, Osaka University Medical School, Osaka, Japan.

Neurology
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased plasma LIGHT levels in patients with atopic dermatitis.

Clinical and experimental immunology·2012
Same author

Histamine prevents apoptosis in human monocytes.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2007
Same author

Effect of serotonin on the differentiation of human monocytes into dendritic cells.

Clinical and experimental immunology·2006
Same author

The role of interleukin-16 in murine contact hypersensitivity.

Clinical and experimental immunology·2005
Same author

Congenital malignant melanoma: a case report.

The British journal of dermatology·2004
Same author

Design of synchrotron light source and its beamline dedicated to dual-energy x-ray computed tomography.

Journal of biomedical optics·2001

Parkinson's disease patients show decreased D3 dopamine receptor (D3R) mRNA expression in lymphocytes. This reduction in D3R mRNA and binding sites correlates with disease severity, offering potential biomarkers for Parkinson's disease.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder.
  • Dopamine receptors (DARs) play a crucial role in motor control.
  • Peripheral biomarkers for PD are actively sought.

Purpose of the Study:

  • To investigate dopamine receptor mRNA expression in Parkinson's disease patients.
  • To explore the correlation between DAR expression and clinical severity in PD.
  • To assess D3 dopamine receptor (D3R) binding in PD lymphocytes.

Main Methods:

  • Quantitative reverse transcription and polymerase chain reaction (RT-PCR) for DAR mRNA expression.
  • Analysis of peripheral blood lymphocytes from 45 PD patients and 21 controls.
  • Beta-actin mRNA as an internal control for relative expression quantification.

Related Experiment Videos

Main Results:

  • A statistically significant decrease in D3 dopamine receptor (D3R) mRNA expression was observed in PD patients compared to controls.
  • No significant change in D5 dopamine receptor mRNA expression was found in PD patients.
  • Reduced D3R binding sites were detected in lymphocytes of PD patients.
  • Decreased D3R mRNA expression correlated with the clinical severity of Parkinson's disease.

Conclusions:

  • Peripheral D3 dopamine receptor (D3R) mRNA expression is significantly reduced in Parkinson's disease.
  • Reduced D3R expression and binding in lymphocytes may serve as a potential biomarker for PD.
  • D3R expression levels correlate with the clinical progression of Parkinson's disease.